CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
Those with T2DM with optimal risk factor control have greater risk for cardiovascular disease events versus those without T2DM
Cardiorespiratory Fitness Reduced With Prolonged ADT in Prostate Cancer
Increased cardiovascular mortality also seen with prolonged androgen deprivation therapy for prostate cancer
AHA: Ablation Better Than Meds for Initial A-Fib Treatment
Findings based on randomized trial evaluating initial treatment with cryoballoon catheter ablation versus standard meds
AHA: Sotagliflozin Beneficial for T2DM With Heart Failure
Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD
USPSTF Urges Behavioral Counseling to Reduce CVD Risk
Behavioral counseling interventions to promote healthy diet and physical activity have moderate net benefit
RSNA: Neurologic Complications of COVID-19 Examined
In patients with critical findings identified on neuroimaging, most common comorbidities were hypertension, diabetes
Non-COVID-19-Related Deaths Up, Too
Excess deaths seen for specific gender and age groups, with protective effect seen for female children
AHA: Obese Patients More Likely to Be Hospitalized for COVID-19
Risk for in-hospital death, mechanical ventilation higher for obese patients; link between BMI and outcomes strongest for adults ≥50 years
AHA: Out-of-Hospital Cardiac Arrest Outcomes Worse During COVID-19
OHCA outcomes worse early in the pandemic even in areas with low case-fatality rates
AHA Meeting Addresses Latest Research, COVID-19, Health Care Disparities
American Heart Association President-Elect Donald Lloyd-Jones, M.D., discussed highlights of the AHA Scientific Sessions 2020 with HD Live!
